Company Overview
| Stock Name | 溫州康寧醫院股份有限公司 - Ｈ股 |
|---|---|
| Stock Code | 02120 |
| Company Full Name | 溫州康寧醫院股份有限公司 - Ｈ股 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國從事經營精神科醫院、提供醫院管理服務，以及從事房地產業務。 |
| Listing Date | 2015-11-20 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省溫州市黃龍住宅區盛錦路 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.knhosp.cn |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 38.70 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 9.5% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 340,560,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 49.1 |
|---|---|
| First Day Open | HK$ 44.0 |
| First Day Change | 26.87% |
| First Day Volume | 13746900.0 |
| First Day Turnover | 640369000.0 |
Use of Proceeds
| Use of Proceeds | 1、約50%或305.6百萬港元將用于通過我們多元化的擴張模式在精神科醫療服務供不應求的地區擴張及提升我們的醫療機構網絡及包括我們現有及未來發展中的機構在內的運營能力； 2、約25%或152.8百萬港元將用于溫州康寧醫院的改造及升級項目，以擴張其運營規模及高端醫療服務能力； 3、約10%或61.1百萬港元將用于科研、教學及人員培訓用途，包括擴大我們與經挑選的國內外精神科醫療機構及大學的合作； 4、約8%或48.9百萬港元將用于發展我們的移動和在線醫療咨詢平臺并改進我們的信息科技基礎設施，而我們相信這將進一步提升我們的品牌知名度及患者覆蓋能力； 5、約7%或42.8百萬港元將用作營運資金及其他一般企業用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
花旗环球金融亚洲有限公司 CE AAA137
中信证券（香港）有限公司 CE AAK249
Overall Coordinators (2)
花旗环球金融亚洲有限公司 CE AAA137
中信里昂证券有限公司 CE AAB893
Joint Bookrunners (3)
花旗环球金融亚洲有限公司 CE AAA137
花旗环球金融亚洲有限公司 CE AAA137
中信里昂证券有限公司 CE AAB893
Joint Lead Managers (3)
花旗环球金融亚洲有限公司 CE AAA137
花旗环球金融亚洲有限公司 CE AAA137
中信里昂证券有限公司 CE AAB893
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Dragon Billion China Master Fund | 108,507,060 HKD | — | 4.40% | — | 6 months | 2016-05-20 |
| 2 | OrbiMed Funds | 139,509,630 HKD | — | 5.10% | — | 6 months | 2016-05-20 |
Directors & Management
| Chairman | 管偉立 |
|---|---|
| Company Secretary | 黃偉超;王健 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 管偉立(29.68%);王紅月(11.32%);上海盛歌投資管理有限公司(8.72%);Guangzhou GL Capital Investment Fund L.P.(7.22%) |
|---|
